David Dalessandro, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Boston, MANPI 1922188580
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $60,600 of the $76,823 with a category attached, or 78.9%. Abiomed accounts for 90.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $39,830 and has fallen 92.6% since, to $2,943 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $685.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$70K
- Paragonix Technologies, Inc.$2K
- Medtronic$2K
- Abbott$1K
- Edwards Lifesciences$1K
- Atricure, Inc.$831
- plus $439 from 1 others
Across 111 payments — averaging $8981.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$743K
- Abbott$87K
- Medtronic$54K
- Atricure, Inc.$35K
- Livanova USA, Inc.$32K
- Briohealth Solutions, Inc.$28K
- plus $19K from 1 others
What the payments were for
- Consulting fees$1,8002%
- Speaking & faculty fees$60,60079%
- Travel & lodging$6,4878%
- Food & beverage$7,93610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 59 | $69,761 |
| Paragonix Technologies, Inc. | 7 | $2,099 |
| Medtronic(2 entities) | 12 | $1,564 |
| Abbott | 20 | $1,125 |
| Edwards Lifesciences | 6 | $1,004 |
| Atricure, Inc. | 7 | $831 |
| Transmedics, Inc. | 1 | $439 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$66,899
- Paragonix SherpaPak Cardiac Transport System$4,500
- HeartWare HVAD$924
- ORGAN CARE SYSTEM$439
- ATRICLIP LAA EXCLUSION SYSTEM$419
- INSPIRIS RESILIA aortic valve$397
- Avalus$328
- Epic$295
- Legacy$160
- Penditure$151
- KONECT RESILIA$137
- SYNERGY ABLATION SYSTEM$131
- ATRICURE ATRICLIP LAA EXCLUSION$123
- SherpaPak$122
- LIVERguard$122
- LUNGguard$122
- BaroGuard$122
- PancreasPak$122
- HeartMate 3 Left Ventricular Assist Device$113
How this compares
$76,823 in reported general payments places this provider in the 90th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Boston
- Lana Schumacher BealBoston$254K
- Sidney LevitskyBoston$248K
- Robert ThurerBoston$229K
- Margaret MarshallBoston$122K
- Pedro del NidoBoston$119K
- Akinobu ItohBoston$102K
- Amy HackmannBoston$80K
- Nathaniel LangerBoston$79K
- Joren MadsenBoston$65K
- Yuji KawanoBoston$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.